With a $3M grant, Dr. Vlad Kalinichenko is working on cutting-edge therapies for premature infants with lung disease. His research at Phoenix Children’s Research Institute focuses on innovative treatments for bronchopulmonary dysplasia (BPD) using gene therapy and advanced drug delivery.